Rhumbline Advisers T2 Biosystems, Inc. Transaction History

Rhumbline Advisers

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$1.47 - $3.16 $56,540 - $121,543	-38,463 Closed	0 $0
Q1 2019 May 01, 2019	BUY	$2.56 - $4.48 $2,536 - $4,439	991 Added 2.64%	38,463 $101,000
Q4 2018 Jan 31, 2019	BUY	$2.98 - $6.86 $42,631 - $98,139	14,306 Added 61.75%	37,472 $113,000
Q3 2018 Nov 07, 2018	BUY	$5.36 - $7.83 $2,856 - $4,173	533 Added 2.35%	23,166 $173,000
Q2 2018 Aug 06, 2018	BUY	$5.97 - $9.58 $135,119 - $216,824	22,633 New	22,633 $175,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $3.38M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.